SCA Pharmaceuticals morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total recall — FDA D-0871-2017
Lack of assurance of sterility: Product bags leaking at seam.
Complete FDA and NHTSA recall records dated in 2017, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Lack of assurance of sterility: Product bags leaking at seam.
Lack of assurance of sterility: Product bags leaking at seam.
Lack of assurance of sterility: Product bags leaking at seam.
Product contains undeclared eggs
Frozen raw tuna cubes from Indonesia tested positive for hepatitis A.
Lord Organics is recalling ginger powder because it has the potential to be contaminated with Salmonella.
The product was made with flour supplied by Ardent Mills who issued a recall on flour products due to possible E. coli 0121 contamination.
US Deer Antler Export and Import is recalling a variety of Herbal Teas because they may be contaminated with Clostridium botulinum
Possible Salmonella contamination.
RB Manufacturing is recalling Move Free Advance Tablets due to incorrect packaging.
The product was made with flour supplied by Ardent Mills who issued a recall on flour products due to possible E. coli 0121 contamination.
The product was made with flour supplied by Ardent Mills who issued a recall on flour products due to possible E. coli 0121 contamination.
The product may be contaminated with Listeria monocytogenes.
Superpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.
Defective Delivery System: Elevated number of units with out of specification results for leak rate
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.
cGMP Deviations: lack of quality assurance at the API manufacturer.
Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the…
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.
Presence of Particulate Matter: human hair found within an internal sample syringe.
Superpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.